Achieving a sustained reduction in benzodiazepine use through implementation of an area-wide multi-strategic approach

Journal of Clinical Pharmacy and Therapeutics

Volumn 30, Issue 5, 2005, Pages 425-432

  Dollman, W B ^a,b,d   LeBlanc, V T ^a   Stevens, L ^a   O'Connor, P J ^a   Roughead, E E ^b,c   Gilbert, A L ^b,c  

^a Department of Health ^*  (Australia)

^b UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

^c University of South Australia City East Campus   (Australia)

^d DEPARTMENT OF HUMAN SERVICES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALPRAZOLAM; AMITRIPTYLINE; BENZODIAZEPINE; DIAZEPAM; FLUNITRAZEPAM; FLUOXETINE; NITRAZEPAM; OXAZEPAM; SERTRALINE; TEMAZEPAM;

ARTICLE; AUSTRALIA; FOLLOW UP; HUMAN; INSOMNIA; PHARMACY; PRESCRIPTION; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; RURAL AREA;

ANTIDEPRESSIVE AGENTS; BENZODIAZEPINES; CLINICAL PROTOCOLS; COMMUNITY PHARMACY SERVICES; CONSUMER PARTICIPATION; DRUG UTILIZATION; HOMES FOR THE AGED; HUMANS; HYPNOTICS AND SEDATIVES; PHARMACISTS; PUBLIC POLICY; SLEEP INITIATION AND MAINTENANCE DISORDERS; SOUTH AUSTRALIA;

EID: 21644480394     PISSN: 02694727     EISSN: 13652710     Source Type: Journal    
DOI: 10.1111/j.1365-2710.2005.00674.x     Document Type: Article

References (20)

1. The Pharmaceutical Health and the Rational Use of Medicines (PHARM) Committee (1992) A policy on the quality use of medicines. Canberra: DHHCS.
2. Commonwealth Department of Health and Ageing (2002) The national strategy for quality use of medicines. Canberra: DHA.
3. Australian Bureau of Statistics (1999) National health survey: use of medications, Australia 1995. Canberra: ABS (Cat. No. 4377.0).
4. Roughead EE (1998) The suitability of performance indicators for evaluating the implementation and effect of Australia's Policy on the Quality Use of Medicines. PhD Thesis, University of South Australia, Adelaide.
5. Cripps R, Carman J (2001) Falls by the elderly in Australia: trends and data for 1998. Adelaide: Australian Institute of Health and Welfare (AIHW cat no. INJCAT 35).
6. Panneman MJ, Goettsch WG, Kramarz P, Herings RM (2003) The costs of benzodiazepine-associated hospital-treated fall injuries in the EU: a Pharmo study. Drugs and Aging, 20, 833-839.
7. Ensrud KE, Blackwell TL, Mangione CM et al. (2002) Study of Osteoporotic Fractures Research Group. Central nervous system-active medications and risk for falls in older women. Journal of the American Geriatrics Society, 50, 1629-1637.
8. Frels C, Williams P, Narayanan S, Gariballa SE (2002) Iatrogenic causes of falls in hospitalised elderly patients: a case-control study. Postgraduate Medical Journal, 78, 487-489.
9. Tromp AM, Pluijm SM, Smit JH, Deeg DJ, Bouter LM, Lips P (2001) Fall-risk screening test: a prospective study on predictors for falls in community-dwelling elderly. Journal of Clinical Epidemiology, 54, 837-844.
10. Leipzig RM, Cumming RG, Tinetti ME (1999) Drugs and falls in older people: a systematic review and meta-analysis: I. Psychotropic drugs. Journal of the American Geriatrics Society, 47, 30-39.
11. Dollman WB, LeBlanc VT, Roughead EE (2003) Managing insomnia in the elderly - what prevents us using non-drug options? Journal of Clinical Pharmacy and therapeutics, 28, 485-491.
12. Campbell DT, Stanley JC (1966) Experimental and quasi-experimental designs for research. Chicago, IL: Rand McNally.
13. SPSS Incorporated (1999) SPSS Base 10.0 user's guide. Chicago, IL: SPSS Inc.
14. Rothman KJ, Greenland S (1998) Modern epidemiology. Philadelphia, PA: Lippincott-Raven.
15. Perneger TV (1998) What is wrong with Bonferroni adjustments. British Medical Journal, 136, 1236-1238.
16. Sankoh AJ, Huque MF, Dubey SD (1997) Some comments on frequently used multiple endpoint adjustments methods in clinical trials. Statistics in Medicine, 16, 2529-2542.
17. Commonwealth Department of Health and Ageing (2003) Australian statistics on medicine. Canberra: DHA.
18. Commonwealth Department of Health and Aged Care (2001) Quality use of medicines: a decade of research, development and service activity 1991-2001. Canberra: DHAC, Pharmaceutical Health and Rational use of Medicines Committee (PHARM) and Australian Pharmaceutical Advisory Council (APAC).
19. Mant A, Rendle VA, Hall WD, Mitchell PB, Montgomery WS, McManus PR, Hickie IB (2004) Making new choices about antidepressants in Australia: the long view 1975-2002. Medical Journal of Australia, 181, S21-S24.
20. McManus P (1993) Drug utilisation (letter). Medical Journal of Australia, 158, 724.